BIBLIOGRAFIA

1.- World medical association declaration of Helsinky. Ethical principles for

medical research involving human subjects. 59th WMA general assembly seoul
octuber 2008.

2.- Douglas G. Altman DSc, Kenneth F. Schulz PhD The revised CONSORT
statement for reporting randomized trials: explanation and elaboration.
Annals of internal medicine 2001; 134: 663-694 (NO SE PUDO)

3.- J. Viby- Mogensen, J Engbaek. Good clinical research practice in

pharmacodynamic Studies of neuromuscular blocking agents. Acta
aneaesthesiologica scandinavica 1996; 40: 59 74. (NO SE PUDO)

4.- T. Fuch- buder C. Claudius. Good clinical research practice in

pharmacodynamic Studies of neuromuscular blocking agents II: the
stockholm revision. Acta Anaesthesiologica sandinavica 2007; 51: 789-808.

(NO SE PUDO)

5.- Casper Claudius, Jorgen Viby- mongensen. Acceleromyography for use in

scientific and clinical practice. A systematic review of evidence.
Anesthesiology 2008; 108: 1117-40.

6.- Glen S. Murphy MD Joseph W. Szokol MD Intraoperative Acceleromyography

monitoring reduces the risk of residual neuromuscular blockade and
adverse respiratory events in the postanesthesia care unit. Anesthesiology
2008; 109: 389-98.

7.- Organizació n Mundial de la Salud. Obesidad y sobrepeso. Nota descriptiva

No 311 septiembre 2006.

8.- Antonio R. Villa. Michelle H. Escobedo. Estimacion y proyeccion de la

prevalencia de obesidad en Mexico a traves de la mortalidad por
enfermedades asociadas. Gaceta medica mexicana Vol. 140 Suplemento No 2
2004.

9.- Mary T. Hawn MD MPH. John Bian PhD. Impact of obesity on resource
utilization for general surgical procederes. Annals of Surgery 2005; 241: 821 –
828.

10.- Kim E. Schultheis MD Yeong Gyoe MD. Fat and neurosurgery: does obesity
affect outcome alter intracraneal surgery? Neurosurgery 2009; 64: 316- 327.
(NO SE PUDO)

11.- Farshad Abir MD Robert Bell MD. Assesment and Management of the obese
patient. Critical care medicine 2004 Vol 32 Suppl No 4.

12.- Frederic M. Pieracci MD Philip S. Barie MD. Critical care of the bariatric
patient. Critical Care Medicine 2006; 34: 1796-1804.

13.- Jay B. Brodsky MD Harry J.M. Lemmens MD PhD. Morbid Obesity and
Tracheal intubation Anesthesia and analgesia 2002; 94: 732-6.
14.- Ziad C. Sifri MD Hyonak Kim MD. The Impact of Obesity on the outcome of
emergency intubation in trauma patients. J. Trauma 2008; 65: 396-400.

(no se pudo)

15.- Lars H. Lundstrom MD. Ann M. Moller MD. High Body Mass Index is a weak
predictor of difficult and failed tracheal intubation. Anesthesiology 2009; 110: 266-
74.

16.- Ronald C. Harper MD. William B. Kelly MD. A Comparison of the volumen
and pH of Gastric content of obese and lean surgical patients. Anesthesia and
analgesia 1998; 66: 147-52.

17.- Richard L. Jones PhD FCCP. The effects of body mass index on lung
volumes. Chest 2006; 130: 827-833.

18.- Garth Davis MD Jitesh A. Patel MD. Pulmonary Considerations in Obesity

and the Bariatric Surgical Patient. The medical clinics of north America 2007;
91: 433-442.

19.- Barbara Kabon MD Angelika Nagele RN. Obesity decreases perioperative

tissue oxygenation. Anesthesiology 2004; 100: 274-80.

20.- B.S. Von Ungen-Stenberg. A. Regil MC Scheinder. Effect of obesity and site of
surgery on perioperative lung volumes. British Journal of anaesthesia 2004; 92:
202-7.

21.- F. Collet, a Mallart. Physiologic correlates of dyspnea in patients with

morbid obesity. International Journal of obesity 2007; 31: 700- 706.

(no se pudo)

22.- Shiro Isomo MD. Obstructive sleep apnea of obese adults. Pathophysiology
and perioperative airway Management. Anesthesiology 2009; 110: 908-21.

23.- Samuel A. Mickelson MD Preoperative and postoperative Management of

obstructive sleep apnea patients. Otolaryngologic clinics of north America 2007;
40: 877-889. (no se pudo)

24.- Charlie K. Lan Mary W. Rose. Preoperative Management of obstructive

sleep apnea. Sleep medicine clinics 2006; 1: 541-548. (no se pudo)

25.- American Society of Anesthesiologysts. Practice Guidelines for the

Perioperative Management of Patients with Obstructive sleep apnea.
Anesthesiology 2006; 104: 1081-93.

26.- Yigal Leykin MD MSc. Tomasso Pellis MD. The Effects of Cisatracurium in
Morbidly Obese Women Anesthesia Analgesia 2004; 99: 1090-4.

27.- Weinstein JA., Matteo RS, Pharmacodynamics of vecuronium and

atracurium in the obese surgical patient. Anesthesia Analgesia 1988; 67: 1149-
53. (no se pudo)
28.- Varin F. Ducharme J, Influence of extreme obesity onthe body disposition
and neuromuscular blocking effect of atracurium. Clinical pharmacology
therapy 1990; 48: 18-25. (no se pudo)

29.- Kisor DF, Schmith VD, Clinical Pharmacokinetics of cisatracurium

besylate. Clinical Pharmacokinetics 1999; 36: 27- 40. (no se pudo)

30.- Alvarez AO, Cascardo A, Total Intravenous Anesthesia with Midazolam,

Remifentanil and cisatracurium in morbid Obesity. Obes. Surg 2000; 10: 353-
60. (NO SE PUDO)

31.- Kirkeergard- Nielsen H, Helbo- Hansen HS, Anthropometric variables as

predictors for the duration of action of atracurium induced neuromuscular
block. Anesthesia Analgesia 1996; 83: 1076-80.

32.- Gaszynski T, W. Strzelck J. General Anesthesia with Remifentanil and

Cisatracurium for a Superobese Patient. European Journal of Anaesthesiology
2002; 20: 77-8. (NO SE PUDO)

33.- Ziya Salihoglu, Sener Demiroluk. Neuromuscular Effects of Cisatracurium in

Morbidly Obese Patient. Middle East Journal of Anesthesia 2008; 19: 831-39.
( NO SE PUDO)

34.- Janeth M. Van Vlymen MD, Joel L. Parlow MD The Effects of Reversal of
Neuromuscular Blockade on Autonomic Control in the Perioperative Period.
Anesthesia Analgesia 1997; 84: 148-54.

35.- Mohamed Naguib, Cynthia A. Lien Pharmacology of Muscle Relaxants and

their Antagonists. Miller´s Anesthesia Sixth Edition ELSEVIER 2005.

36.- Jason A. Campagna, Peter F. Dunn, Bloqueo Neuromuscular Massachussetts

General Hospital Anestesia 2005 editorial Marban.